Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 8/20 | 0.58 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.58 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | CDC25A | P30304 | 1/20 | 0.46 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.46 |
| ▸ | AKT1 | P31749 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 7/20 | 0.43 |
| ▸ | CA2 | P00918 | 7/20 | 0.43 |
| ▸ | CA9 | Q16790 | 7/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA3 | P07451 | 2/20 | 0.41 |
| ▸ | CA4 | P22748 | 2/20 | 0.41 |
| ▸ | CA6 | P23280 | 2/20 | 0.41 |
| ▸ | CA5A | P35218 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28954648 | 0.98 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL17686773 | 0.98 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL29085821 | 0.98 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL393907 | 0.98 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL21764574 | 0.98 | CYP3A4 (0.58) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL9463219 | 0.98 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL21764586 | 0.95 | LPAR3 (0.59) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL617402 | 0.92 | CYP3A4 (0.64) | LPAR3LPAR2LPAR1CYP3A4CA1 | |
| SCHEMBL28854940 | 0.89 | LPAR3 (0.53) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL28969148 | 0.89 | LPAR3 (0.53) | LPAR3LPAR2LPAR1CYP3A4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 368 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114686574-B | Method and kit for detecting nucleotide large fragment deletion | 厦门大学 | 2024-07-02 | — | — | CN | claimed |
| WO-2023198181-A1 | CARBOBICYCLIC NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTION | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2023-10-19 | — | — | WO | claimed |
| US-11788118-B2 | Method for detecting target nucleic acid sequences | XIAMEN ZEESAN BIOTECH CO., LTD. (CN) | 2023-10-17 | — | — | US | claimed |
| CN-111100862-B | Method for detecting bacterial serotypes | 厦门大学 | 2023-09-29 | — | — | CN | claimed |
| EP-3640340-B1 | METHOD FOR DETECTING TARGET NUCLEIC ACID SEQUENCES | XIAMEN ZEESAN BIOTECH CO LTD (CN) | 2022-06-29 | — | — | EP | claimed |
| US-20220017949-A1 | METHOD FOR DETECTING TARGET NUCLEIC ACID SEQUENCES | XIAMEN ZEESAN BIOTECH CO., LTD. (CN) | 2022-01-20 | — | — | US | claimed |
| US-11111522-B2 | Method for detecting target nucleic acid sequences | XIAMEN UNIVERSITY (CN) | 2021-09-07 | — | — | US | claimed |
| WO-2021128860-A1 | METHOD FOR ASYMMETRIC AMPLIFICATION OF TARGET NUCLEIC ACID | 厦门大学 | 2021-07-01 | — | — | WO | claimed |
| WO-2021128823-A1 | METHOD FOR ASYMMETRIC AMPLIFICATION OF MULIPLE TARGET NUCLEIC ACIDS | 厦门大学 | 2021-07-01 | — | — | WO | claimed |
| US-20200140931-A1 | METHOD FOR DETECTING TARGET NUCLEIC ACID SEQUENCES | XIAMEN ZEESAN BIOTECH CO., LTD. (CN) | 2020-05-07 | — | — | US | claimed |
| EP-3640340-A1 | METHOD FOR DETECTING TARGET NUCLEIC ACID SEQUENCES | Xiamen University (CN) | 2020-04-22 | — | — | EP | claimed |
| US-6197944-B1 | OLIGODEOXYNUCLEOTIDES | INTEGRATED DNA TECHNOLOGIES, INC. | 2001-03-06 | — | — | US | claimed |
| JP-3019994-B2 | — | — | 2000-03-15 | — | — | JP | claimed |
| WO-1989005358-A1 | DNA AND RNA MOLECULES STABILIZED BY MODIFICATIONS OF THE 3'-TERMINAL PHOSPHODIESTER LINKAGE AND THEIR USE AS NUCLEIC ACID PROBES AND AS THERAPEUTIC AGENTS TO BLOCK THE EXPRESSION OF SPECIFICALLY TARGETED GENES | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 1989-06-15 | — | — | WO | claimed |
| US-12036295-B2 | Moist wipe having enhanced dispersibility | NICE-PAK PRODUCTS, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| WO-2024147408-A1 | (R,RP)-ISOMER OF 2'-FLUORO-6'-METHYLENE CARBOCYCLIC ADENOSINE MONOPHOSPHATE PRODRUG, AND USE THEREOF | IMMUNODESIGNERS CO., LTD. (KR) | 2024-07-11 | — | — | WO | disclosed |
| US-20240124511-A1 | COMPOSITIONS AND METHODS OF MODULATING THE IMMUNE RESPONSE BY ACTIVATING ALPHA PROTEIN KINASE 1 | TIANJIN HONGKE BAISHI QIXIN VENTURE CAPITAL PARTNERSHIP (LIMITED PARTNERSHIP) (CN) | 2024-04-18 | — | — | US | disclosed |
| EP-0476071-A4 | EXONUCLEASE-RESISTANT OLIGONUCLEOTIDES AND METHODS FOR PREPARING THE SAME | — | 1992-11-04 | — | — | EP | disclosed |
| EP-0476071-A1 | EXONUCLEASE-RESISTANT OLIGONUCLEOTIDES AND METHODS FOR PREPARING THE SAME | GILEAD SCIENCES, INC. (US) | 1992-03-25 | — | — | EP | disclosed |
| WO-1990015065-A1 | EXONUCLEASE-RESISTANT OLIGONUCLEOTIDES AND METHODS FOR PREPARING THE SAME | GILEAD SCIENCES, INC. (US) | 1990-12-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240124511-A1 | COMPOSITIONS AND METHODS OF MODULATING THE IMMUNE RESPONSE BY ACTIVATING ALPHA PROTEIN KINASE 1 | PHKA1, PHKA2, PRKCA | LPAR3 912/4885LPAR2 681/4885LPAR1 464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.